Envestnet Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21B Buy
4,942,508
+383,311
+8% +$89.3M 0.32% 60
2025
Q4
$944M Sell
4,559,197
-576,181
-11% -$114M 0.28% 66
2025
Q3
$952M Buy
5,135,378
+214,830
+4% +$36.8M 0.27% 67
2025
Q2
$752M Buy
4,920,548
+209,345
+4% +$32.2M 0.22% 84
2025
Q1
$781M Buy
4,711,203
+168,535
+4% +$26.4M 0.25% 74
2024
Q4
$657M Buy
4,542,668
+128,374
+3% +$19.9M 0.21% 82
2024
Q3
$715M Buy
4,414,294
+130,947
+3% +$20.9M 0.23% 77
2024
Q2
$626M Buy
4,283,347
+109,184
+3% +$16.2M 0.22% 82
2024
Q1
$660M Buy
4,174,163
+205,583
+5% +$32.7M 0.25% 73
2023
Q4
$622M Buy
3,968,580
+11,151
+0.3% +$1.71M 0.26% 70
2023
Q3
$616M Buy
3,957,429
+719,472
+22% +$119M 0.28% 62
2023
Q2
$536M Sell
3,237,957
-1,156,721
-26% -$187M 0.24% 69
2023
Q1
$509M Buy
4,394,678
+1,091,780
+33% +$176M 0.24% 67
2022
Q4
$583M Buy
3,302,898
+167,306
+5% +$28.9M 0.3% 60
2022
Q3
$512M Buy
3,135,592
+208,468
+7% +$35.3M 0.29% 60
2022
Q2
$520M Buy
2,927,124
+193,972
+7% +$34.6M 0.29% 64
2022
Q1
$484M Buy
2,733,152
+60,541
+2% +$10.3M 0.24% 74
2021
Q4
$457M Buy
2,672,611
+146,657
+6% +$24M 0.23% 82
2021
Q3
$408M Buy
2,525,954
+99,575
+4% +$17M 0.22% 80
2021
Q2
$400M Buy
2,426,379
+142,525
+6% +$23.6M 0.23% 79
2021
Q1
$375M Buy
2,283,854
+551,775
+32% +$89.3M 0.24% 76
2020
Q4
$273M Buy
1,732,079
+50,618
+3% +$7.47M 0.21% 78
2020
Q3
$250M Buy
1,681,461
+35,941
+2% +$5.32M 0.22% 76
2020
Q2
$231M Buy
1,645,520
+123,515
+8% +$18M 0.23% 81
2020
Q1
$200M Buy
1,522,005
+171,077
+13% +$24.3M 0.24% 69
2019
Q4
$197M Buy
1,350,928
+132,904
+11% +$18M 0.21% 81
2019
Q3
$158M Buy
1,218,024
+7,966
+0.7% +$1.05M 0.17% 99
2019
Q2
$169M Buy
1,210,058
+123,412
+11% +$17.1M 0.21% 76
2019
Q1
$152M Buy
1,086,646
+53,711
+5% +$7.19M 0.21% 75
2018
Q4
$133M Buy
1,032,935
+882,125
+585% +$123M 0.21% 83
2018
Q3
$20.8M Sell
150,810
-179,634
-54% -$23.9M 0.04% 183
2018
Q2
$40.1M Buy
330,444
+90,431
+38% +$11.3M 0.09% 111
2018
Q1
$30.5M Sell
240,013
-405,380
-63% -$54.8M 0.09% 96
2017
Q4
$90.2M Buy
645,393
+27,127
+4% +$3.78M 0.2% 63
2017
Q3
$80.4M Sell
618,266
-41,996
-6% -$5.57M 0.19% 65
2017
Q2
$87.3M Buy
660,262
+17,994
+3% +$2.3M 0.24% 60
2017
Q1
$80M Sell
642,268
-19,239
-3% -$2.3M 0.26% 59
2016
Q4
$76.2M Buy
661,507
+39,645
+6% +$4.58M 0.28% 58
2016
Q3
$73.5M Sell
621,862
-300,562
-33% -$36.5M 0.28% 52
2016
Q2
$112M Sell
922,424
-25,623
-3% -$2.91M 0.45% 41
2016
Q1
$103M Buy
948,047
+4,644
+0.5% +$481K 0.44% 44
2015
Q4
$96.9M Buy
943,403
+6,383
+0.7% +$642K 0.44% 44
2015
Q3
$87.5M Sell
937,020
-35,253
-4% -$3.41M 0.43% 45
2015
Q2
$94.8M Buy
972,273
+59,617
+7% +$5.97M 0.45% 40
2015
Q1
$91.8M Buy
912,656
+872,786
+2,189% +$88.8M 0.47% 34
2014
Q4
$4.17M Sell
39,870
-4,268
-10% -$450K 0.04% 244
2014
Q3
$4.71M Buy
44,138
+41,205
+1,405% +$4.27M 0.05% 252
2014
Q2
$307K Sell
2,933
-31,801
-92% -$3.21M ﹤0.01% 880
2014
Q1
$3.41M Sell
34,734
-850
-2% -$78.8K 0.04% 246
2013
Q4
$3.26M Buy
35,584
+2,866
+9% +$264K 0.04% 250
2013
Q3
$2.84M Buy
32,718
+1,155
+4% +$104K 0.03% 245
2013
Q2
$2.71M Buy
+31,563
New +$2.68M 0.04% 236

Other funds holding JNJ

Envestnet Asset Management's JNJ Position: Q1 2026 in Review

Envestnet Asset Management increased its Johnson & Johnson (JNJ) stake by 8.4% in Q1 2026, buying an estimated $89.3M and bringing the position to 4,942,508 shares worth $1.21B. The position accounts for 0.32% of the portfolio, ranked #60.

Envestnet Asset Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Envestnet Asset Management held 4,942,508 shares of Johnson & Johnson worth $1.21B as of Q1 2026.
  • Envestnet Asset Management bought 383,311 Johnson & Johnson shares in Q1 2026, an estimated $89.3M.
  • Johnson & Johnson made up 0.32% of Envestnet Asset Management's portfolio in Q1 2026, its #60 holding.
  • Envestnet Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.